Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
Not yet recruitingOBSERVATIONAL
Enrollment
400
Participants
Timeline
Start Date
March 31, 2025
Primary Completion Date
January 31, 2030
Study Completion Date
December 31, 2030
Conditions
Esophageal CancerNeoadjuvant Therapy
All Listed Sponsors
lead
Henan Cancer Hospital
OTHER_GOV
NCT06833775 - Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI | Biotech Hunter | Biotech Hunter